Cite
HARVARD Citation
Martin, P. et al. (2017). Long‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphoma. British journal of haematology. pp. 250-256. [Online].